U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840586) titled 'Acceptability and Efficacy of a Culturally Adapted, Low-Frequency Parent-Mediated Early St... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840469) titled 'A Persian AI-Based CBT Chatbot and Voice Analysis System for Managing Perceived Stress' on... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842146) titled 'The Effect of Urolithin A (Mitopure(R)) on Alzheimer's Disease' on Aug. 05. Brief Summary... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842029) titled 'Evaluation of Blood-Based Biomarkers and Remote Cognitive Assessment for Dementia Triage (... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841899) titled 'Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-C... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841080) titled 'Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical S... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841665) titled 'AI-Based Personalized Self-Management for Patients With Heart Failure' on Sept. 20. Brief... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842913) titled 'Hybrid Telerehabilitation for Anterior Knee Pain in Routine Physiotherapy Practice' on Sep... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840625) titled 'Flavored Ready-to-Drink Alcohol Restriction in Young Adults: Behavioral and Biomarker Outc... Read More
U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842887) titled 'Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EG... Read More